FibroGenesis Identifies Mechanism Responsible for Blocking COV...
HOUSTON, July 2, 2020 /PRNewswire-AsiaNet/ -- -- Regenerative Medicine Company Advances Development of Fibroblast-Based Product as an "Off the Shelf" Cell-Treatment for Coronavirus Acute Respiratory Distress Syndrome (ARDS)FibroGenesis announced today identification of molecular mechan...
Authors: LATEST ASIANET NEWS RELEASES